Combined Effect of Diabetes and Frailty on Mortality and Incident Disability in Older Japanese Adults
Overview
Authors
Affiliations
Aim: Evidence is limited on how frailty affects the association between diabetes and adverse outcomes at the population level. The present community-based study aimed to clarify the relative risks of death and disability in older Japanese adults with diabetes, frailty, both or neither.
Methods: The present prospective study analyzed data from 1271 Japanese residents aged ≥65 years in Kusatsu town in Gunma Prefecture, Japan, who participated in annual health checkups carried out between 2002 and 2011, and were initially free of disability. A Cox proportional hazards regression model was used to identify associations of diabetes and frailty with all-cause mortality and incident disability.
Results: Among the 1271 participants, 176 (14%) had diabetes (mean hemoglobin A1c 7.5%, body mass index 24.2 kg/m , 45% using diabetes medications) and 151 (12%) had frailty at baseline. Compared with non-frail participants without diabetes, those with diabetes and frailty had higher risks of mortality (multivariable hazard ratio 5.0, 95% CI 2.4-10.3) and incident disability (hazard ratio 3.9, 95% CI 2.1-7.3). In contrast, non-frail participants with diabetes did not have a significantly increased risk of mortality, although they had a higher tendency for the incidence of disability, as compared with non-frail participants without diabetes.
Conclusions: At the population level, the risks of death and disability in persons with mild diabetes were strongly affected by the presence of frailty. From a community-based perspective, diabetes-related mortality and disability incidence might be reduced by preventing or improving frailty in conjunction with glycemic control. Geriatr Gerontol Int 2019; 19: 423-428.
Liu Y, Zhang L, Li X, Luo A, Guo S, Liu X PLoS One. 2024; 19(10):e0309837.
PMID: 39480799 PMC: 11527323. DOI: 10.1371/journal.pone.0309837.
Yu J, Ye A, Fei Y, Wang D, Zhang Y, Li X Eur Geriatr Med. 2024; 15(6):1891-1898.
PMID: 39405027 DOI: 10.1007/s41999-024-01081-z.
Guevara E, Simo-Servat A, Perea V, Quiros C, Puig-Jove C, Formiga F J Clin Med. 2024; 13(17).
PMID: 39274537 PMC: 11396781. DOI: 10.3390/jcm13175325.
Cheng M, He M, Ning L, Gan H, Liu Q, Liu H Medicine (Baltimore). 2024; 103(26):e38621.
PMID: 38941383 PMC: 11466167. DOI: 10.1097/MD.0000000000038621.
Miao Z, Zhang Q, Yin J, Li L, Feng Y Diabetol Metab Syndr. 2024; 16(1):116.
PMID: 38802895 PMC: 11131325. DOI: 10.1186/s13098-024-01352-6.